"CAN is the most studied and clinically important form of DAN. Meta-analyses of published data demonstrate that reduced cardiovascular autonomic function as measured by heart rate variability (HRV) is strongly associated with an increased risk of silent myocardial ischemia and mortality. The determination of the presence of CAN is usually based on a battery of autonomic function tests..."
TECHNICAL REVIEW: Standard of Care - Diabetic Autonomic Neuropathy
Aaron I. Vinik, MD, PHD; Braxton D. Mitchell, PHD
Raelene E. Maser, PHD; Roy Freeman, MD
Raelene E. Maser, PHD; Roy Freeman, MD
Reduced Heart Rate Variability associated with incresed mortality
These results support an association between CAN (cardiovascular autonomic neuropathy) and increased risk of mortality. The stronger association observed in studies defining CAN by the presence of two or more abnormalities may be due to more severe autonomic dysfunction in these subjects or a higher frequency of other comorbid complications that contributed to their higher mortality risk. Future studies should evaluate whether early identification of subjects with CAN can lead to a reduction in mortality.
- Raelene E. Maser, PHD1,
- Braxton D. Mitchell, PHD2,
- Aaron I. Vinik, MD, PHD3 and
- Roy Freeman, MD4
No comments:
Post a Comment